US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.2901

-0.0175-5.69%

Post-market: 0.2605-0.0296-10.20%19:57 EDT

Volume:7.06M

Turnover:2.30M

Market Cap:17.98M

PE:-0.40

High:0.3034

Open:0.2915

Low:0.2700

Close:0.3076

Loading ...

Overview Company News Filings

Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference

Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD

Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study

Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit

Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit

Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)

B. Riley Adjusts Cognition Therapeutics Price Target to $2 From $1.50, Maintains Buy Rating

MT Newswires Live

Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley

Director Makes Bold Move with Major Stock Purchase in Cognition Therapeutics

Cognition’s Positive Phase 2 ‘Shimmer’ Study of Zervimesine (Ct1812) in Dementia With Lewy Bodies (Dlb) Will Be Presented in a Podium Presentation at Ilbdc

THOMSON REUTERS

Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC

Cognition Therapeutics Shows Promising Phase 2 Study Results

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations

B. Riley Upgrades Cognition Therapeutics to Buy From Neutral, Lifts PT to $1.50 From $1

MT Newswires Live

B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data

Cognition Therapeutics upgraded to Buy from Neutral at B. Riley

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live

Cognition Therapeutics Shares More Than Double as Dementia Drug Meets Main Goal in Mid-Stage Trial

THOMSON REUTERS

Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump

MT Newswires Live

BUZZ-Cognition Therapeutics rises as dementia drug meets main goal in mid-stage trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CGTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.2901,"timestamp":1749153600000,"preClose":0.3076,"halted":0,"volume":7063217,"hourTrading":{"tag":"盘后","latestPrice":0.2605,"preClose":0.2901,"latestTime":"19:57 EDT","volume":27386,"amount":7883.4961,"timestamp":1749167873895},"delay":0,"floatShares":55655757,"shares":61993046,"eps":-0.721131,"marketStatus":"Not Yet Opened","change":-0.0175,"latestTime":"06-05 16:00:00 EDT","open":0.2915,"high":0.3034,"low":0.27,"amount":2300401.9104805198,"amplitude":0.108583,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.721131,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749196800000},"marketStatusCode":0,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.3076,"preHourTrading":{"tag":"盘前","latestPrice":0.285,"preClose":0.3076,"latestTime":"09:29 EDT","volume":2440599,"amount":786376.20273177,"timestamp":1749130152321},"postHourTrading":{"tag":"盘后","latestPrice":0.2605,"preClose":0.2901,"latestTime":"19:57 EDT","volume":27386,"amount":7883.4961,"timestamp":1749167873895},"volumeRatio":2.108212},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","floatShares":55655757,"roa":"-107.53%","roe":"-161.93%","lyrEps":-0.855043,"volumeRatio":2.108212,"shares":61993046,"dividePrice":0,"high":0.3034,"amplitude":0.108583,"preClose":0.3076,"low":0.27,"week52Low":0.222301,"pbRate":"1.47","week52High":2.535,"institutionHeld":0,"latestPrice":0.2901,"eps":-0.721131,"divideRate":0,"volume":7063217,"delay":0,"ttmEps":-0.721131,"open":0.2915,"prevYearClose":0.7013,"prevWeekClose":0.239,"prevMonthClose":0.239,"prevQuarterClose":0.4208,"fiveDayClose":0.2486,"twentyDayClose":0.3547,"sixtyDayClose":0.4087},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518240276","title":"Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240276","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518240276?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606200,"startTime":"0","endTime":"0","summary":"PURCHASE, N.Y., March  10, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039641/0/en/Cognition-Therapeutics-to-Present-at-Life-Sciences-Virtual-Investor-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240878834.USD","CGTX","LU0345774391.USD","BK4007","BK4139","DLB","LENZ","BK4097","LU0205194284.USD","LU0345774631.USD","LU0348723411.USD","LU0205193047.USD","LU0240877869.USD"],"gpt_icon":0},{"id":"2514809905","title":"Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809905","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809905?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"Collaborators at the University of Southampton, UK and Cognition Scientists Show Rescue of Function in a Cell Model of Dry AMDPURCHASE, N.Y., Feb.  27, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033753/0/en/Cognition-Therapeutics-Publishes-Research-Supporting-the-Potential-of-Zervimesine-in-Dry-AMD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0642271901.SGD","BK4532","BK4007","BK4534","LU0345774631.USD","LU1880398471.USD","IE0004445239.USD","LU0345774391.USD","BK4141","BK4139","LU1316542783.SGD","LU1852331112.SGD","LU2458330243.SGD","LU0240877869.USD","LU0719512351.SGD","LU0198837287.USD","LU1989764664.SGD","LU0127658192.USD","LU0823434740.USD","BK4585","LU2098885051.SGD","BK4529","LU1242518931.SGD","GFS","LU0979878070.USD","LU2250418816.HKD","LU0082616367.USD","LU0240878834.USD","LU2054465674.USD","LU1951200564.SGD","LU1988902786.USD","BK4554","LU2458330169.SGD","LENZ","LU1064131342.USD","LU2360106780.USD","CGTX","CSF","LU1951198990.SGD","DLB","LU2264538146.SGD","LU0823434583.USD","LU1303367103.USD","IE00BMPRXN33.USD","LU1803068979.SGD","LU1880398554.USD","LU0081259029.USD","BK4543","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2514983473","title":"Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514983473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514983473?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:33","pubTimestamp":1740573228,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) reported a positive outcome of an analysis of masked data from the ongoing ‘MAGNIFY’ Phase 2 trial of zervimesine in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-passes-pre-defined-futility-analysis-of-phase-2-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-passes-pre-defined-futility-analysis-of-phase-2-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CGTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2514995770","title":"Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514995770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514995770?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:02","pubTimestamp":1740488539,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that Mary Hamby, PhD will be co-hosting a precision medicine workshop at the Hanson Wade Neuroimmunology Dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-vp-co-hosting-workshop-at-neuroimmunology-drug-development-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-vp-co-hosting-workshop-at-neuroimmunology-drug-development-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","CGTX","BK4007","SMMF"],"gpt_icon":0},{"id":"2514264095","title":"Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514264095","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514264095?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"PITTSBURGH, Feb. 25, 2025  -- Cognition Therapeutics, Inc.,  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today announced that Mary Hamby, PhD will be co-hosting a precision medicine workshop at the Hanson Wade Neuroimmunology Drug Development Summit. The workshop will review methods of screening participants for clinical trials to ensure that the patients selected are most likely to benefit from treatment.Dr. Hamby will present an overview of the findings from Cognition’s Phase 2 ‘SHINE’ study of zervimesine  in adults with mild-to-moderate Alzheimer’s disease. Participants with lower levels of a protein called p-tau217 at the beginning of the SHINE study experienced a robust response to zervimesine treatment. Specifically, these individuals with lower p-tau217 levels scored 95% better on the ADAS-Cog 11 scale and 108% better on the MMSE scale than did their counterparts on placebo.Forward-Looking Statements This press release contains forward-lo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-vp-research-co-123000803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0345774391.USD","DLB","LENZ","LU0205193047.USD","LU0240878834.USD","LU0345774631.USD","LU0348723411.USD","BK4007","SMMF","CGTX","BK4139","BK4211","LU0205194284.USD","BK4097","LU0240877869.USD"],"gpt_icon":0},{"id":"2512441455","title":"Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512441455","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512441455?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:30","pubTimestamp":1740054600,"startTime":"0","endTime":"0","summary":"- Chemical process enhances room temperature stability -. PURCHASE, N.Y., Feb. 20, 2025  -- Cognition Therapeutics, Inc.,  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today announced that the American Chemical Society journal Organic Process Research & Development has published a manuscript describing the novel chemical process used to manufacture zervimesine . With this new manufacturing process, Cognition will be able to produce materials for future clinical studies of zervimesine. In addition, if zervimesine is approved, this process is expected to support commercial manufacturing needs.Provisional patent applications covering this chemical process and a preferred polymorphic form of zervimesine have been filed.About Cognition Therapeutics, Inc.Cognition Therapeutics, Inc., is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the CNS. We","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-announces-publication-commercial-123000600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4007","CNS","DLB","LU0240877869.USD","LU0345774391.USD","LU0240878834.USD","LENZ","LU0205194284.USD","BK4135","LU0345774631.USD","CGTX","LU0205193047.USD","LU0348723411.USD","BK4139"],"gpt_icon":0},{"id":"2509029277","title":"B. Riley Adjusts Cognition Therapeutics Price Target to $2 From $1.50, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2509029277","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509029277?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:06","pubTimestamp":1738854397,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) has an average rating of Buy and mean price target of $7.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RILY","LENZ","CGTX"],"gpt_icon":0},{"id":"2509279398","title":"Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2509279398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509279398?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:50","pubTimestamp":1738849808,"startTime":"0","endTime":"0","summary":"B. Riley raised the firm’s price target on Cognition Therapeutics (CGTX) to $2 from $1.50 and keeps a Buy rating on the shares. The firm updated it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-raised-to-2-from-1-50-at-b-riley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-raised-to-2-from-1-50-at-b-riley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CGTX","RILY"],"gpt_icon":0},{"id":"2509544370","title":"Director Makes Bold Move with Major Stock Purchase in Cognition Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2509544370","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509544370?lang=en_us&edition=fundamental","pubTime":"2025-02-05 10:05","pubTimestamp":1738721156,"startTime":"0","endTime":"0","summary":"New insider activity at Cognition Therapeutics ( ($CGTX) ) has taken place on February 5, 2025. Director Lisa Ricciardi has made a significant inve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/director-makes-bold-move-with-major-stock-purchase-in-cognition-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/director-makes-bold-move-with-major-stock-purchase-in-cognition-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CGTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2507364799","title":"Cognition’s Positive Phase 2 ‘Shimmer’ Study of Zervimesine (Ct1812) in Dementia With Lewy Bodies (Dlb) Will Be Presented in a Podium Presentation at Ilbdc","url":"https://stock-news.laohu8.com/highlight/detail?id=2507364799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507364799?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:30","pubTimestamp":1738240238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2507470866","title":"Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC","url":"https://stock-news.laohu8.com/highlight/detail?id=2507470866","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507470866?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:30","pubTimestamp":1738240200,"startTime":"0","endTime":"0","summary":"–Study demonstrated strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with mild-to-moderate DLB–。–Zervimesine-treated participants tested 86% better on behavioral outcomes , 52% on activities of daily living, 91% on cognitive fluctuations, 62% on motor symptoms compared to placebo–。“Dr. Galvin’s presentation is an important opportunity to educate an international audience of advocates, scientists and physicians about the impressive efficacy signals that were observed in participants treated with zervimesine ,” stated Anthony O. Caggiano, MD, PhD, Cognition’s CMO and head of R&D. “DLB is a complex disease with an array of physical and psychological symptoms that can progress rapidly and are ultimately fatal. Zervimesine-treated participants tested higher across behavioral, cognitive, functional and motor symptoms than their placebo-treated counterparts.”Participants treated with zervimesine also preserved 52% more of their ability t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-positive-phase-2-shimmer-123000174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0205194284.USD","BK4097","CDR","BK4080","LU0240878834.USD","DLB","CGTX","LU0205193047.USD","LU0240877869.USD","LU0348723411.USD","LU0345774631.USD","LU0345774391.USD","CAF","BK4007"],"gpt_icon":0},{"id":"2503533014","title":"Cognition Therapeutics Shows Promising Phase 2 Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2503533014","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503533014?lang=en_us&edition=fundamental","pubTime":"2025-01-14 01:14","pubTimestamp":1736788467,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics ( ($CGTX) ) has issued an announcement. Cognition Therapeutics announced promising results from their Phase 2 SHIMMER study,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-shows-promising-phase-2-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-shows-promising-phase-2-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2502861325","title":"Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2502861325","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502861325?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:00","pubTimestamp":1736514000,"startTime":"0","endTime":"0","summary":"AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc.  , a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Mike Buhle as SVP of Commercial Operations.Mr. Buhle has over 25 years of experience driving commercial growth and new product launches in the diagnostics and life science tools domains, working for start-up, scale-up, and established businesses. He brings hands-on leadership experience in clinical diagnostics specializing in precision medicine and patient outcomes in oncology, rare diseases, infectious diseases, and drug development and preventative interventions. Prior to joining Aspira, Mr. Buhle served as Chief Commercial Officer at Biovision Diagnostics and Vice President of Sales, Americas for Congenica.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aspira-womens-health-announces-appointment-130000770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","LU0553294199.USD","LU1061106388.HKD","LU0820561909.HKD","LU2087621335.USD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","LU0128525929.USD","LU0965508806.USD","LU0203347892.USD","LU2112291526.USD","LU0882574055.USD","BK4559","CGTX","BK4007","BK4585","AWH","SG9999015952.SGD","ABBV","IE00B3PB1722.GBP","LU0029864427.USD","IE00BJT1NW94.SGD","LU1989771016.USD","LU0198837287.USD","LU1037948541.HKD","CPA","BK4550","IE0009355771.USD","LU2468319806.SGD","BK4533","IE0004445239.USD","IE00BSNM7G36.USD","LU1934455863.HKD","LU0689472784.USD","LU0985320562.USD","LU0211327993.USD","LU1732800096.USD","LU1267930573.SGD","LU0310799852.SGD","LU1291159041.SGD","LU1934455277.USD","LU0738911758.USD","LU0949170772.SGD","LU2089284900.SGD","SG9999015978.USD","LU0417517546.SGD","LU0456855351.SGD","LU0234572021.USD","IE0002141913.USD","LU1732799900.SGD"],"gpt_icon":0},{"id":"2492120571","title":"B. Riley Upgrades Cognition Therapeutics to Buy From Neutral, Lifts PT to $1.50 From $1","url":"https://stock-news.laohu8.com/highlight/detail?id=2492120571","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492120571?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:15","pubTimestamp":1734614107,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) has an average rating of buy and mean price target of $7.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RILY","CGTX","PT","LENZ"],"gpt_icon":0},{"id":"2492242891","title":"B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data","url":"https://stock-news.laohu8.com/highlight/detail?id=2492242891","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492242891?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:21","pubTimestamp":1734610896,"startTime":"0","endTime":"0","summary":"B. Riley analyst Mayank Mamtani upgraded Cognition Therapeutics (CGTX) to Buy from Neutral with a price target of $1.50, up from $1. The company’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/b-riley-upgrades-cognition-therapeutics-to-buy-on-lewy-bodies-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/b-riley-upgrades-cognition-therapeutics-to-buy-on-lewy-bodies-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","RILY","LENZ"],"gpt_icon":0},{"id":"2492121940","title":"Cognition Therapeutics upgraded to Buy from Neutral at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2492121940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492121940?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:05","pubTimestamp":1734609947,"startTime":"0","endTime":"0","summary":"B. Riley upgraded Cognition Therapeutics (CGTX) to Buy from Neutral with a $1.50 price target Published first on TheFly – the ultimate source for r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-upgraded-to-buy-from-neutral-at-b-riley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-upgraded-to-buy-from-neutral-at-b-riley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","RILY","LENZ"],"gpt_icon":0},{"id":"2492713207","title":"Sector Update: Health Care Stocks Advance in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2492713207","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492713207?lang=en_us&edition=fundamental","pubTime":"2024-12-19 02:49","pubTimestamp":1734547778,"startTime":"0","endTime":"0","summary":"Health care stocks were rising Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.The iShares Biotechnology ETF (IBB) shed 0.7%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756168.USD","IE00B2B36J28.USD","LU1989771016.USD","XLV","SG9999014575.USD","IE00BSNM7G36.USD","IE00BLSP4239.USD","SG9999014542.SGD","LU1037948897.HKD","IBB","LU1983299246.USD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","LU1585245621.USD","BK4007","BK4139","LU0985320562.USD","MRK","LU1989772840.SGD","LU2461242641.AUD","LU1699723380.USD","LU2468319806.SGD","LU1066053197.SGD","BK4585","LU1989772923.USD","LU2089984988.USD","LU1941712348.USD","LU0211331839.USD","SG9999002224.SGD","LU2361044949.HKD","LU1066051498.USD","LU0203347892.USD","BK4550","LU0965509010.AUD","LU0234572021.USD","LU0106261372.USD","LU0203345920.USD","IE0002141913.USD","LU1093756325.SGD","LU0289739699.SGD","SG9999015358.SGD","LU1934455194.USD","CGTX","LU2361044865.SGD","BK4533","IE00BFTCPJ56.SGD","LU0861579265.USD","KALV","LU1571399168.USD"],"gpt_icon":0},{"id":"2492181888","title":"Cognition Therapeutics Shares More Than Double as Dementia Drug Meets Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492181888?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:31","pubTimestamp":1734532279,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGTX","BK4007"],"gpt_icon":0},{"id":"2492918633","title":"Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918633","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918633?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:49","pubTimestamp":1734529761,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics  said Wednesday that a phase 2 study of CT1812 to treat patients with Lewy body dementia met its primary endpoint of safety and tolerability.The drug produced \"strong therapeutic responses across behavioral, functional, cognitive and movement measures\" in patients who received the treatment for six months, compared to placebo.The results showed a 82% slowing in neuropsychiatric inventory decline and a 91% reduction in attention fluctuations, while reducing anxiety, hallucinations and delusions, Cognition said.The company said it expects to review the results with the Food and Drug Administration in an end-of-phase 2 meeting and to advance CT1812 into late-stage trials.Cognition Therapeutics shares were 135% higher in recent premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","CGTX","BK4007"],"gpt_icon":1},{"id":"2492900700","title":"BUZZ-Cognition Therapeutics rises as dementia drug meets main goal in mid-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492900700","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492900700?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:45","pubTimestamp":1734525942,"startTime":"0","endTime":"0","summary":"BUZZ-Cognition Therapeutics rises as dementia drug meets main goal in mid-stage trial ** Shares of Cognition Therapeutics CGTX.O rise 76.7% to 81 cents premarket ** Drug developer says its experimental oral drug, CT1812, met the main goal of safety and tolerability in a mid-stage study  ** The study enrolled 130 patients with mild-to-moderate dementia with Lewy bodies - a type of dementia that affects thinking, movement, behavior, and mood     ** Co says \"patients treated with CT1812 for six months experienced improvement in behavioral, functional, cognitive and movement measures compared to placebo\"** Adds, \"there was a marked reduction in caregiver distress, which suggests a positive impact on the day-to-day lives of those receiving the drug\" ** Says detailed data will be presented at a medical conference in January 2025 ** Says expediting plans to advance CT1812 into late-stage trials** Up to last close, stock down 75.4% YTD    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4N3NJ0WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"CGTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-20","symbol":"CGTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-11-13","symbol":"CGTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-08","symbol":"CGTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-05-07","symbol":"CGTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1738123200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGTX","date":"2025-06-04","current":-0.576926,"percent":0.936269,"low":-56.313627,"twenty":-3.627114,"median":-2.37865,"eighty":-0.859087,"high":-0.444935,"avg":-5.580269,"sd":10.540162,"marketCap":19211644},"quantilePoints":[{"date":"2021-10-08","current":-54.318634,"twenty":-53.008521,"median":-51.043352,"eighty":-51.043352,"marketCap":267573589},{"date":"2021-10-15","current":-51.628056,"twenty":-52.877541,"median":-52.429288,"eighty":-51.277234,"marketCap":254319802},{"date":"2021-10-22","current":-52.061905,"twenty":-52.877541,"median":-52.319436,"eighty":-51.801596,"marketCap":256456944},{"date":"2021-10-29","current":-52.452369,"twenty":-52.782095,"median":-52.474061,"eighty":-52.061905,"marketCap":258380371},{"date":"2021-11-05","current":-52.148675,"twenty":-52.955634,"median":-52.495754,"eighty":-52.061905,"marketCap":256884372},{"date":"2021-11-12","current":-50.933897,"twenty":-52.999019,"median":-52.582524,"eighty":-52.061905,"marketCap":250900376},{"date":"2021-11-19","current":-36.38032,"twenty":-52.955634,"median":-52.495754,"eighty":-51.043352,"marketCap":227195098},{"date":"2021-11-26","current":-31.475505,"twenty":-52.903572,"median":-52.365599,"eighty":-46.578051,"marketCap":196564527},{"date":"2021-12-03","current":-29.323032,"twenty":-52.790772,"median":-52.10529,"eighty":-35.646362,"marketCap":183122334},{"date":"2021-12-10","current":-28.405584,"twenty":-52.756064,"median":-52.061905,"eighty":-31.172041,"marketCap":177392875},{"date":"2021-12-17","current":-18.525381,"twenty":-52.747387,"median":-51.043352,"eighty":-29.591209,"marketCap":115691005},{"date":"2021-12-23","current":-21.736447,"twenty":-52.712679,"median":-50.456663,"eighty":-29.181886,"marketCap":135744113},{"date":"2021-12-31","current":-22.30103,"twenty":-52.625909,"median":-38.074069,"eighty":-22.30103,"marketCap":139269934},{"date":"2022-01-07","current":-20.289703,"twenty":-52.625909,"median":-35.921596,"eighty":-22.054025,"marketCap":126709196},{"date":"2022-01-14","current":-22.054025,"twenty":-52.539139,"median":-31.475505,"eighty":-22.054025,"marketCap":137727387},{"date":"2022-01-21","current":-12.350254,"twenty":-52.504431,"median":-31.12264,"eighty":-21.708218,"marketCap":77127337},{"date":"2022-01-28","current":-12.244395,"twenty":-52.495754,"median":-29.975831,"eighty":-21.073062,"marketCap":76466245},{"date":"2022-02-04","current":-15.56132,"twenty":-52.461046,"median":-29.323032,"eighty":-20.106214,"marketCap":97180444},{"date":"2022-02-11","current":-14.149862,"twenty":-52.382953,"median":-28.793735,"eighty":-17.974913,"marketCap":88365891},{"date":"2022-02-18","current":-11.609239,"twenty":-52.328669,"median":-25.018086,"eighty":-15.554263,"marketCap":72499696},{"date":"2022-02-25","current":-10.233068,"twenty":-52.216979,"median":-24.312357,"eighty":-14.904992,"marketCap":63905507},{"date":"2022-03-04","current":-8.856896,"twenty":-52.096613,"median":-22.35396,"eighty":-14.432154,"marketCap":55311318},{"date":"2022-03-11","current":-9.492052,"twenty":-52.061905,"median":-22.054025,"eighty":-12.98541,"marketCap":59277867},{"date":"2022-03-18","current":-10.550646,"twenty":-52.061905,"median":-22.054025,"eighty":-12.597259,"marketCap":65888782},{"date":"2022-03-25","current":-10.515359,"twenty":-51.801596,"median":-21.736447,"eighty":-11.524551,"marketCap":65668418},{"date":"2022-04-01","current":-5.010611,"twenty":-51.277234,"median":-21.20715,"eighty":-10.74825,"marketCap":58704318},{"date":"2022-04-08","current":-6.032005,"twenty":-51.043352,"median":-20.677854,"eighty":-10.451844,"marketCap":70670967},{"date":"2022-04-14","current":-5.588758,"twenty":-50.99957,"median":-20.32499,"eighty":-10.275412,"marketCap":65477893},{"date":"2022-04-22","current":-6.070548,"twenty":-50.55211,"median":-19.33697,"eighty":-9.449708,"marketCap":71122539},{"date":"2022-04-29","current":-5.342796,"twenty":-48.27874,"median":-17.996085,"eighty":-9.287391,"marketCap":62596202},{"date":"2022-05-06","current":-5.786422,"twenty":-42.666251,"median":-15.878898,"eighty":-8.856896,"marketCap":67793721},{"date":"2022-05-13","current":-4.18241,"twenty":-37.961153,"median":-15.526034,"eighty":-6.50994,"marketCap":65985888},{"date":"2022-05-20","current":-3.938914,"twenty":-37.227195,"median":-14.855591,"eighty":-6.062092,"marketCap":62144244},{"date":"2022-05-27","current":-3.838651,"twenty":-36.013341,"median":-14.538013,"eighty":-5.911684,"marketCap":60562390},{"date":"2022-06-03","current":-3.566507,"twenty":-35.13118,"median":-14.326295,"eighty":-5.79028,"marketCap":56268788},{"date":"2022-06-10","current":-2.750078,"twenty":-33.338629,"median":-13.214772,"eighty":-5.589715,"marketCap":43387981},{"date":"2022-06-17","current":-2.377672,"twenty":-31.454333,"median":-12.844264,"eighty":-5.461433,"marketCap":37512525},{"date":"2022-06-24","current":-2.635491,"twenty":-31.369645,"median":-12.667832,"eighty":-5.323508,"marketCap":41580148},{"date":"2022-07-01","current":-3.222748,"twenty":-31.12264,"median":-12.297325,"eighty":-5.12624,"marketCap":50845290},{"date":"2022-07-08","current":-3.365981,"twenty":-30.727432,"median":-11.50338,"eighty":-4.150899,"marketCap":53105081},{"date":"2022-07-15","current":-2.878988,"twenty":-30.233422,"median":-10.832937,"eighty":-3.861568,"marketCap":45421793},{"date":"2022-07-22","current":-3.036544,"twenty":-29.880558,"median":-10.638862,"eighty":-3.746982,"marketCap":47907562},{"date":"2022-07-29","current":-2.707108,"twenty":-29.591209,"median":-10.480073,"eighty":-3.577966,"marketCap":42710044},{"date":"2022-08-05","current":-4.4832,"twenty":-29.365376,"median":-10.374213,"eighty":-3.555048,"marketCap":70731448},{"date":"2022-08-12","current":-2.561319,"twenty":-29.266574,"median":-10.162495,"eighty":-3.489161,"marketCap":51326263},{"date":"2022-08-19","current":-2.334653,"twenty":-29.196001,"median":-9.456765,"eighty":-3.268697,"marketCap":46784116},{"date":"2022-08-26","current":-2.334653,"twenty":-28.560844,"median":-9.350907,"eighty":-3.151131,"marketCap":46784116},{"date":"2022-09-02","current":-2.130654,"twenty":-27.812772,"median":-9.20976,"eighty":-3.036544,"marketCap":42696183},{"date":"2022-09-09","current":-2.096655,"twenty":-26.076679,"median":-8.892183,"eighty":-2.98689,"marketCap":42014861},{"date":"2022-09-16","current":-1.983322,"twenty":-24.615821,"median":-8.751037,"eighty":-2.936281,"marketCap":39743788},{"date":"2022-09-23","current":-1.892656,"twenty":-24.326472,"median":-6.533066,"eighty":-2.878988,"marketCap":37926929},{"date":"2022-09-30","current":-2.153321,"twenty":-23.423139,"median":-6.128363,"eighty":-2.844612,"marketCap":43150398},{"date":"2022-10-07","current":-2.187321,"twenty":-22.576265,"median":-6.04423,"eighty":-2.724296,"marketCap":43831720},{"date":"2022-10-14","current":-2.062655,"twenty":-22.343374,"median":-5.954918,"eighty":-2.618303,"marketCap":41333539},{"date":"2022-10-21","current":-1.937989,"twenty":-22.173999,"median":-5.832135,"eighty":-2.511452,"marketCap":38835358},{"date":"2022-10-28","current":-2.209987,"twenty":-22.06814,"median":-5.762203,"eighty":-2.37906,"marketCap":44285935},{"date":"2022-11-04","current":-2.028655,"twenty":-22.054025,"median":-5.59115,"eighty":-2.341453,"marketCap":40652217},{"date":"2022-11-11","current":-1.908266,"twenty":-22.054025,"median":-5.554965,"eighty":-2.293854,"marketCap":38239736},{"date":"2022-11-18","current":-1.80798,"twenty":-22.054025,"median":-5.41764,"eighty":-2.243987,"marketCap":42585160},{"date":"2022-11-25","current":-3.050198,"twenty":-21.969337,"median":-5.333152,"eighty":-2.243987,"marketCap":71844352},{"date":"2022-12-02","current":-3.456071,"twenty":-21.799962,"median":-5.222598,"eighty":-2.243987,"marketCap":81404286},{"date":"2022-12-09","current":-2.819045,"twenty":-21.679989,"median":-5.141318,"eighty":-2.251626,"marketCap":66399786},{"date":"2022-12-16","current":-2.737629,"twenty":-21.454155,"median":-4.4832,"eighty":-2.264513,"marketCap":64482102},{"date":"2022-12-23","current":-2.904609,"twenty":-21.214208,"median":-4.168087,"eighty":-2.264513,"marketCap":68415151},{"date":"2022-12-30","current":-2.584609,"twenty":-21.171864,"median":-4.117955,"eighty":-2.266654,"marketCap":60877889},{"date":"2023-01-06","current":-2.781532,"twenty":-21.171864,"median":-3.953237,"eighty":-2.266654,"marketCap":65516204},{"date":"2023-01-13","current":-2.732301,"twenty":-20.677854,"median":-3.838651,"eighty":-2.289838,"marketCap":64356625},{"date":"2023-01-20","current":-2.498456,"twenty":-20.508479,"median":-3.795681,"eighty":-2.307557,"marketCap":58848626},{"date":"2023-01-27","current":-2.486148,"twenty":-20.353219,"median":-3.716902,"eighty":-2.321053,"marketCap":58558731},{"date":"2023-02-03","current":-2.609225,"twenty":-20.29676,"median":-3.580831,"eighty":-2.332386,"marketCap":61457678},{"date":"2023-02-10","current":-2.289225,"twenty":-19.555745,"median":-3.53786,"eighty":-2.332386,"marketCap":53920416},{"date":"2023-02-17","current":-2.215379,"twenty":-19.315798,"median":-3.509214,"eighty":-2.289715,"marketCap":52181047},{"date":"2023-02-24","current":-1.864611,"twenty":-18.835902,"median":-3.408951,"eighty":-2.266654,"marketCap":43919048},{"date":"2023-03-03","current":-2.079995,"twenty":-18.207803,"median":-3.294436,"eighty":-2.243987,"marketCap":48992205},{"date":"2023-03-10","current":-2.087168,"twenty":-17.932569,"median":-3.197788,"eighty":-2.24239,"marketCap":49161146},{"date":"2023-03-17","current":-2.211404,"twenty":-16.725773,"median":-3.151131,"eighty":-2.225141,"marketCap":52087404},{"date":"2023-03-24","current":-2.653148,"twenty":-15.864783,"median":-3.136292,"eighty":-2.218944,"marketCap":56769418},{"date":"2023-03-31","current":-2.707853,"twenty":-15.660122,"median":-3.098992,"eighty":-2.225141,"marketCap":57939922},{"date":"2023-04-06","current":-2.502712,"twenty":-15.547206,"median":-3.050198,"eighty":-2.229674,"marketCap":53550534},{"date":"2023-04-14","current":-2.448008,"twenty":-15.427232,"median":-3.036544,"eighty":-2.23559,"marketCap":52380030},{"date":"2023-04-21","current":-2.297572,"twenty":-15.208456,"median":-2.985617,"eighty":-2.241592,"marketCap":49161146},{"date":"2023-04-28","current":-2.33977,"twenty":-14.904992,"median":-2.950605,"eighty":-2.243987,"marketCap":50064065},{"date":"2023-05-05","current":-2.285039,"twenty":-14.608586,"median":-2.920445,"eighty":-2.241592,"marketCap":48892975},{"date":"2023-05-12","current":-1.960622,"twenty":-14.580357,"median":-2.893311,"eighty":-2.217756,"marketCap":46527513},{"date":"2023-05-19","current":-2.467425,"twenty":-14.523899,"median":-2.871827,"eighty":-2.205838,"marketCap":58554454},{"date":"2023-05-26","current":-2.430413,"twenty":-14.432154,"median":-2.858289,"eighty":-2.210554,"marketCap":57676137},{"date":"2023-06-02","current":-3.071944,"twenty":-14.291008,"median":-2.850341,"eighty":-2.212199,"marketCap":72900295},{"date":"2023-06-09","current":-3.701137,"twenty":-13.994602,"median":-2.864665,"eighty":-2.216567,"marketCap":87831681},{"date":"2023-06-16","current":-3.6888,"twenty":-13.310045,"median":-2.878988,"eighty":-2.222594,"marketCap":87538908},{"date":"2023-06-23","current":-3.269338,"twenty":-13.055983,"median":-2.893311,"eighty":-2.227687,"marketCap":77584651},{"date":"2023-06-30","current":-2.158997,"twenty":-12.914837,"median":-2.893311,"eighty":-2.226414,"marketCap":51235147},{"date":"2023-07-07","current":-1.961603,"twenty":-12.858379,"median":-2.878988,"eighty":-2.210837,"marketCap":46550790},{"date":"2023-07-14","current":-2.220682,"twenty":-12.759576,"median":-2.864665,"eighty":-2.20302,"marketCap":52699008},{"date":"2023-07-21","current":-2.134322,"twenty":-12.681946,"median":-2.850341,"eighty":-2.185861,"marketCap":50649602},{"date":"2023-07-28","current":-2.072637,"twenty":-12.561973,"median":-2.826229,"eighty":-2.183671,"marketCap":49185741},{"date":"2023-08-04","current":-2.183671,"twenty":-12.406712,"median":-2.808868,"eighty":-2.180597,"marketCap":51820691},{"date":"2023-08-11","current":-2.24283,"twenty":-12.286739,"median":-2.785721,"eighty":-2.183671,"marketCap":50923457},{"date":"2023-08-18","current":-2.029227,"twenty":-11.863301,"median":-2.744609,"eighty":-2.168944,"marketCap":46073604},{"date":"2023-08-25","current":-2.029227,"twenty":-11.482208,"median":-2.736692,"eighty":-2.147762,"marketCap":46073604},{"date":"2023-09-01","current":-2.069278,"twenty":-11.334005,"median":-2.721529,"eighty":-2.134322,"marketCap":46982952},{"date":"2023-09-07","current":-2.029227,"twenty":-11.291661,"median":-2.717274,"eighty":-2.134322,"marketCap":46073604},{"date":"2023-09-13","current":-1.922426,"twenty":-11.016427,"median":-2.715721,"eighty":-2.130654,"marketCap":43648678},{"date":"2023-09-22","current":-1.708823,"twenty":-10.804708,"median":-2.707853,"eighty":-2.110595,"marketCap":38798824},{"date":"2023-09-28","current":-1.788924,"twenty":-10.755307,"median":-2.702213,"eighty":-2.099254,"marketCap":40617519},{"date":"2023-10-05","current":-1.828975,"twenty":-10.727078,"median":-2.692436,"eighty":-2.087168,"marketCap":41526867},{"date":"2023-10-11","current":-1.802274,"twenty":-10.621219,"median":-2.686743,"eighty":-2.085321,"marketCap":40920635},{"date":"2023-10-20","current":-1.695473,"twenty":-10.543589,"median":-2.684528,"eighty":-2.080991,"marketCap":38495709},{"date":"2023-10-27","current":-1.49522,"twenty":-10.536531,"median":-2.683071,"eighty":-2.079135,"marketCap":33948971},{"date":"2023-11-03","current":-1.361718,"twenty":-10.508302,"median":-2.666389,"eighty":-2.072637,"marketCap":30917813},{"date":"2023-11-10","current":-1.332388,"twenty":-10.480073,"median":-2.653148,"eighty":-2.069278,"marketCap":30417082},{"date":"2023-11-17","current":-1.332388,"twenty":-10.423615,"median":-2.646148,"eighty":-2.06131,"marketCap":30417082},{"date":"2023-11-24","current":-1.345712,"twenty":-10.4095,"median":-2.628512,"eighty":-2.052945,"marketCap":30721252},{"date":"2023-11-30","current":-1.425655,"twenty":-10.395385,"median":-2.607276,"eighty":-2.048349,"marketCap":32546277},{"date":"2023-12-07","current":-1.812047,"twenty":-10.353042,"median":-2.598444,"eighty":-2.042577,"marketCap":41367231},{"date":"2023-12-14","current":-2.345003,"twenty":-10.338927,"median":-2.595483,"eighty":-2.042577,"marketCap":53534064},{"date":"2024-01-05","current":-2.771916,"twenty":-10.275412,"median":-2.592521,"eighty":-2.045808,"marketCap":63280072},{"date":"2024-01-12","current":-2.842269,"twenty":-10.190724,"median":-2.607276,"eighty":-2.047962,"marketCap":64886165},{"date":"2024-01-19","current":-3.236247,"twenty":-10.035464,"median":-2.628512,"eighty":-2.048736,"marketCap":73880287},{"date":"2024-01-26","current":-3.194035,"twenty":-9.703771,"median":-2.653148,"eighty":-2.050467,"marketCap":72916631},{"date":"2024-02-02","current":-3.222177,"twenty":-9.463823,"median":-2.665604,"eighty":-2.051322,"marketCap":73559068},{"date":"2024-02-09","current":-3.165894,"twenty":-9.39325,"median":-2.683071,"eighty":-2.052945,"marketCap":72274194},{"date":"2024-02-16","current":-2.785987,"twenty":-9.350907,"median":-2.688118,"eighty":-2.055599,"marketCap":63601290},{"date":"2024-02-23","current":-2.828199,"twenty":-9.350907,"median":-2.696348,"eighty":-2.057273,"marketCap":64564946},{"date":"2024-03-01","current":-2.912622,"twenty":-9.329735,"median":-2.707853,"eighty":-2.062655,"marketCap":66492258},{"date":"2024-03-08","current":-2.771916,"twenty":-9.230932,"median":-2.7149,"eighty":-2.06398,"marketCap":63280072},{"date":"2024-03-15","current":-2.5285,"twenty":-9.125073,"median":-2.714167,"eighty":-2.069278,"marketCap":57723128},{"date":"2024-03-22","current":-2.684756,"twenty":-8.913354,"median":-2.707853,"eighty":-2.069278,"marketCap":61290288},{"date":"2024-03-28","current":-2.288672,"twenty":-8.856896,"median":-2.702213,"eighty":-2.069278,"marketCap":59020277},{"date":"2024-04-05","current":-2.918811,"twenty":-8.856896,"median":-2.707853,"eighty":-2.072637,"marketCap":75270293},{"date":"2024-04-12","current":-3.160785,"twenty":-8.751037,"median":-2.716454,"eighty":-2.072637,"marketCap":81510317},{"date":"2024-04-19","current":-2.7827,"twenty":-8.504032,"median":-2.721529,"eighty":-2.072637,"marketCap":71760279},{"date":"2024-04-26","current":-2.918811,"twenty":-6.648695,"median":-2.734028,"eighty":-2.073988,"marketCap":75270293},{"date":"2024-05-03","current":-3.074207,"twenty":-6.417436,"median":-2.737629,"eighty":-2.078562,"marketCap":79277655},{"date":"2024-05-10","current":-2.658425,"twenty":-6.321078,"median":-2.741119,"eighty":-2.079995,"marketCap":76474910},{"date":"2024-05-17","current":-2.70148,"twenty":-6.128363,"median":-2.73733,"eighty":-2.084974,"marketCap":77713486},{"date":"2024-05-24","current":-3.620541,"twenty":-6.070548,"median":-2.741119,"eighty":-2.085321,"marketCap":104152094},{"date":"2024-05-31","current":-2.743256,"twenty":-6.059274,"median":-2.744609,"eighty":-2.085321,"marketCap":78915241},{"date":"2024-06-07","current":-2.548304,"twenty":-6.036895,"median":-2.743256,"eighty":-2.085321,"marketCap":73307051},{"date":"2024-06-14","current":-3.063534,"twenty":-5.997316,"median":-2.744609,"eighty":-2.086429,"marketCap":88128695},{"date":"2024-06-21","current":-2.840732,"twenty":-5.966481,"median":-2.750078,"eighty":-2.089222,"marketCap":81719335},{"date":"2024-06-28","current":-2.325501,"twenty":-5.958772,"median":-2.750078,"eighty":-2.091276,"marketCap":66897691},{"date":"2024-07-05","current":-2.464753,"twenty":-5.911684,"median":-2.744609,"eighty":-2.094508,"marketCap":70903541},{"date":"2024-07-12","current":-2.548304,"twenty":-5.868281,"median":-2.740443,"eighty":-2.096384,"marketCap":73307051},{"date":"2024-07-15","current":-2.757181,"twenty":-5.863421,"median":-2.743256,"eighty":-2.09652,"marketCap":79315826},{"date":"2024-08-02","current":-1.253264,"twenty":-5.858561,"median":-2.740443,"eighty":-2.095978,"marketCap":36052648},{"date":"2024-08-09","current":-0.753562,"twenty":-5.80571,"median":-2.735755,"eighty":-2.085321,"marketCap":23422203},{"date":"2024-08-16","current":-0.828948,"twenty":-5.786422,"median":-2.729518,"eighty":-2.078562,"marketCap":25765360},{"date":"2024-08-23","current":-0.979372,"twenty":-5.762203,"median":-2.717274,"eighty":-2.072637,"marketCap":30440850},{"date":"2024-08-30","current":-0.916749,"twenty":-5.593541,"median":-2.71552,"eighty":-2.062655,"marketCap":28494402},{"date":"2024-09-06","current":-0.785693,"twenty":-5.593541,"median":-2.714787,"eighty":-2.054568,"marketCap":24420906},{"date":"2024-09-13","current":-0.779366,"twenty":-5.589715,"median":-2.714099,"eighty":-2.047962,"marketCap":24224255},{"date":"2024-09-20","current":-0.786855,"twenty":-5.577154,"median":-2.70748,"eighty":-2.041187,"marketCap":24457026},{"date":"2024-09-27","current":-0.52939,"twenty":-5.558823,"median":-2.70018,"eighty":-2.029227,"marketCap":16454514},{"date":"2024-10-04","current":-0.561541,"twenty":-5.551165,"median":-2.692436,"eighty":-2.027934,"marketCap":17453824},{"date":"2024-10-11","current":-0.528099,"twenty":-5.461433,"median":-2.685985,"eighty":-2.017322,"marketCap":16414381},{"date":"2024-10-18","current":-0.575357,"twenty":-5.404682,"median":-2.680114,"eighty":-1.999884,"marketCap":17883247},{"date":"2024-10-25","current":-0.761677,"twenty":-5.353445,"median":-2.666389,"eighty":-1.984892,"marketCap":23674433},{"date":"2024-10-31","current":-0.685625,"twenty":-5.331223,"median":-2.659705,"eighty":-1.983322,"marketCap":21310602},{"date":"2024-11-08","current":-0.67168,"twenty":-5.309214,"median":-2.653148,"eighty":-1.978496,"marketCap":20877166},{"date":"2024-11-15","current":-0.599125,"twenty":-5.253433,"median":-2.64578,"eighty":-1.966526,"marketCap":20532022},{"date":"2024-11-22","current":-0.515042,"twenty":-5.213707,"median":-2.633673,"eighty":-1.956102,"marketCap":17650476},{"date":"2024-11-29","current":-0.487374,"twenty":-5.187226,"median":-2.619731,"eighty":-1.937989,"marketCap":16702293},{"date":"2024-12-06","current":-0.458398,"twenty":-5.144334,"median":-2.609225,"eighty":-1.922426,"marketCap":15709296},{"date":"2024-12-13","current":-0.616612,"twenty":-5.079988,"median":-2.598985,"eighty":-1.90713,"marketCap":21131310},{"date":"2024-12-20","current":-0.768644,"twenty":-4.799647,"median":-2.592521,"eighty":-1.866762,"marketCap":26341428},{"date":"2024-12-27","current":-0.930374,"twenty":-4.449963,"median":-2.590079,"eighty":-1.848993,"marketCap":31883931},{"date":"2025-01-03","current":-0.876666,"twenty":-4.317013,"median":-2.584832,"eighty":-1.825371,"marketCap":30043355},{"date":"2025-01-10","current":-0.953652,"twenty":-4.209331,"median":-2.584609,"eighty":-1.806839,"marketCap":32681652},{"date":"2025-01-17","current":-0.84175,"twenty":-4.17244,"median":-2.560657,"eighty":-1.775574,"marketCap":28846772},{"date":"2025-01-24","current":-0.953046,"twenty":-4.160238,"median":-2.557163,"eighty":-1.730183,"marketCap":32660878},{"date":"2025-01-31","current":-0.931466,"twenty":-4.14517,"median":-2.548304,"eighty":-1.695473,"marketCap":31921324},{"date":"2025-02-07","current":-0.775797,"twenty":-4.113658,"median":-2.535095,"eighty":-1.682123,"marketCap":26586562},{"date":"2025-02-14","current":-0.7153,"twenty":-4.019124,"median":-2.52911,"eighty":-1.620963,"marketCap":24513317},{"date":"2025-02-21","current":-0.739062,"twenty":-3.959688,"median":-2.5285,"eighty":-1.507172,"marketCap":25327657},{"date":"2025-02-28","current":-0.55563,"twenty":-3.944293,"median":-2.516839,"eighty":-1.437461,"marketCap":19041446},{"date":"2025-03-07","current":-0.522896,"twenty":-3.910267,"median":-2.502712,"eighty":-1.402377,"marketCap":17919650},{"date":"2025-03-14","current":-0.503134,"twenty":-3.855839,"median":-2.492302,"eighty":-1.377689,"marketCap":17242417},{"date":"2025-03-21","current":-0.521872,"twenty":-3.827192,"median":-2.467425,"eighty":-1.352114,"marketCap":17728529},{"date":"2025-03-28","current":-0.822207,"twenty":-3.804275,"median":-2.463143,"eighty":-1.332388,"marketCap":27931206},{"date":"2025-04-04","current":-0.704176,"twenty":-3.778493,"median":-2.449225,"eighty":-1.016109,"marketCap":23921557},{"date":"2025-04-11","current":-0.582678,"twenty":-3.741252,"median":-2.44554,"eighty":-0.978985,"marketCap":19794158},{"date":"2025-04-17","current":-0.680825,"twenty":-3.721199,"median":-2.436234,"eighty":-0.953167,"marketCap":23128303},{"date":"2025-04-25","current":-0.805241,"twenty":-3.70802,"median":-2.434332,"eighty":-0.930592,"marketCap":27354858},{"date":"2025-05-02","current":-0.815822,"twenty":-3.69867,"median":-2.424964,"eighty":-0.918859,"marketCap":27714301},{"date":"2025-05-09","current":-0.614146,"twenty":-3.681398,"median":-2.421867,"eighty":-0.914274,"marketCap":20451072},{"date":"2025-05-16","current":-0.586607,"twenty":-3.651109,"median":-2.389648,"eighty":-0.902546,"marketCap":19534008},{"date":"2025-05-23","current":-0.586421,"twenty":-3.644136,"median":-2.387687,"eighty":-0.894261,"marketCap":19527809},{"date":"2025-05-30","current":-0.462807,"twenty":-3.627114,"median":-2.379986,"eighty":-0.876545,"marketCap":15411471},{"date":"2025-06-04","current":-0.576926,"twenty":-3.627114,"median":-2.37865,"eighty":-0.859087,"marketCap":19211644}],"updateTime":1749183875819}}}